• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

    2/14/23 12:22:03 PM ET
    $CBT
    Major Chemicals
    Industrials
    Get the next $CBT alert in real time by email
    SC 13G/A 1 r13ga1-cabot20221231.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 Cabot Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 127055101 (CUSIP Number) December 30, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) For IA & IAR [ ] Rule 13d-1(c) For LP if any [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out or a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 127055101 SCHEDULE 13G Page 2 of 5 1 Name of Reporting Person Fuller & Thaler Asset Management, Inc. IRS Identification No. of Above Person 94-3176968 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization California 5 Sole Voting Power 2,074,254 NUMBER OF 6 Shared Voting Power SHARES BENEFICIALLY -0- OWNED BY EACH REPORTING 7 Sole Dispositive Power PERSON WITH 2,114,157 8 Shared Dispositive Power -0- 9 Aggregate Amount Beneficially Owned by each Reporting Person 2,114,157 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* [ ] 11 Percent of Class Represented by Amount in Row 9 3.75% 12 Type of Reporting Person* IA CUSIP No. 127055101 SCHEDULE 13G Page 3 of 5 Item 1(a). Name of Issuer. Cabot Corporation Item 1(b). Address of Issuer's Principal Executive Offices. Two Seaport Lane Suite 1300 Boston, MA 02210 Item 2(a). Names of Persons Filing. Fuller & Thaler Asset Management, Inc. Item 2(b). Address of Principal Business Office or, if none, Residence. 411 Borel Avenue, Suite 300, San Mateo, CA 94402. Item 2(c). Citizenship. California corporation. Item 2(d). Title of Class of Securities. Common Stock Item 2(e). CUSIP Number. 127055101 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company act of 1940 (15 U.S.C. 80a-8). CUSIP No. 127055101 SCHEDULE 13G Page 4 of 5 (e) [X] An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with 240.13b-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded form the definition of an investment company under section 3(c)(14) of the Investment Company act of 1940 (15 U.S.C. 80a-3). (j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Reference is made hereby to Items 5-9 and 11 of Page two (2) of this Schedule 13G, which Items are incorporated by reference herein. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. CUSIP No. 127055101 SCHEDULE 13G Page 5 of 5 Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below, Fuller & Thaler Asset Management, Inc. certifies that, to the best of its knowledge and belief, the securities referred to above on page two (2) of this Schedule 13G were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATED: February 13, 2023 Fuller & Thaler Asset Management, Inc. /s/ Hanna Zanoni ________________________ By: Hanna Zanoni its: Chief Compliance Officer
    Get the next $CBT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBT

    DatePrice TargetRatingAnalyst
    11/11/2024$105.00Neutral → Underweight
    JP Morgan
    4/18/2024Buy → Hold
    Deutsche Bank
    3/27/2024$104.00Buy
    Mizuho
    1/8/2024$90.00 → $87.00Buy → Neutral
    UBS
    6/6/2023$87.00 → $80.00Overweight → Neutral
    JP Morgan
    3/13/2023$94.00Outperform
    Credit Suisse
    11/16/2022$80.00 → $90.00Hold → Buy
    Deutsche Bank
    1/4/2022$75.00 → $70.00Buy
    UBS
    More analyst ratings

    $CBT
    SEC Filings

    View All

    Cabot Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CABOT CORP (0000016040) (Filer)

    11/3/25 5:30:29 PM ET
    $CBT
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Cabot Corporation

    10-Q - CABOT CORP (0000016040) (Filer)

    8/5/25 3:41:17 PM ET
    $CBT
    Major Chemicals
    Industrials

    Cabot Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CABOT CORP (0000016040) (Filer)

    8/4/25 4:53:47 PM ET
    $CBT
    Major Chemicals
    Industrials

    $CBT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SVP and General Counsel Kalita Karen A

    4 - CABOT CORP (0000016040) (Issuer)

    10/2/25 4:40:44 PM ET
    $CBT
    Major Chemicals
    Industrials

    SEC Form 4 filed by President and CEO Keohane Sean D

    4 - CABOT CORP (0000016040) (Issuer)

    10/2/25 4:40:09 PM ET
    $CBT
    Major Chemicals
    Industrials

    SEC Form 4 filed by Executive Vice President, CFO Mclaughlin Erica

    4 - CABOT CORP (0000016040) (Issuer)

    10/2/25 4:39:02 PM ET
    $CBT
    Major Chemicals
    Industrials

    $CBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cabot downgraded by JP Morgan with a new price target

    JP Morgan downgraded Cabot from Neutral to Underweight and set a new price target of $105.00

    11/11/24 7:37:34 AM ET
    $CBT
    Major Chemicals
    Industrials

    Cabot downgraded by Deutsche Bank

    Deutsche Bank downgraded Cabot from Buy to Hold

    4/18/24 8:26:59 AM ET
    $CBT
    Major Chemicals
    Industrials

    Mizuho initiated coverage on Cabot with a new price target

    Mizuho initiated coverage of Cabot with a rating of Buy and set a new price target of $104.00

    3/27/24 8:08:28 AM ET
    $CBT
    Major Chemicals
    Industrials

    $CBT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cabot Corp Reports Fourth Quarter and Fiscal Year 2025 Results

    Fourth Quarter 2025 Diluted earnings per share ("EPS") of $0.79 and Adjusted EPS of $1.70Fiscal Year 2025 Diluted EPS of $6.02 and Adjusted EPS of $7.25 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its fourth quarter and fiscal year 2025. Fiscal Year Highlights Fiscal year Diluted EPS of $6.02 and Adjusted EPS of $7.25, which represents a 3% increase in Adjusted EPS year-over-year Fiscal year segment EBIT decreased 5% in Reinforcement Materials and increased 18% in Performance Chemicals year-over-year Fiscal year 2025 Cash Flows from Operations of $665 million enabled capital investments of $274 million and the payment of $96 millio

    11/3/25 4:30:00 PM ET
    $CBT
    Major Chemicals
    Industrials

    Cabot Corporation Appoints Robert Rist as Vice President of Investor Relations and Corporate Planning

    BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced that Robert Rist has been appointed Vice President of Investor Relations and Corporate Planning. The transition will take place over the course of the first quarter of fiscal year 2026. In this expanded role, Rist succeeds Steve Delahunt, who will continue with the company as Vice President of Treasury. Rist joined Cabot in 2007 and has held a variety of leadership positions across the organization. Most recently, he served as Vice President of Corporate Strategy and Corporate Planning. His prior roles include senior-level positions within the company's Reinforcement Materials segment and finance organi

    11/3/25 4:30:00 PM ET
    $CBT
    Major Chemicals
    Industrials

    Cabot Corporation Strengthens Manufacturing Capabilities in North America for Circular Reinforcing Carbons Powered by its EVOLVE® Sustainable Solutions Technology Platform

    BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced that it has enhanced its manufacturing capabilities in North America for circular reinforcing carbons powered by its EVOLVE® Sustainable Solutions technology platform. With this milestone, Cabot's site in Ville Platte, Louisiana, USA joins Mauá, Brazil and Valasske Mezirici (Valmez), Czech Republic as manufacturing locations with demonstrated circular reinforcing carbons production capability. The circular reinforcing carbons are made using tire pyrolysis oil (TPO) derived from end-of-life tires that leverage an International Sustainability & Carbon Certification (ISCC) PLUS mass balance approach. Furthe

    10/7/25 9:00:00 AM ET
    $CBT
    Major Chemicals
    Industrials

    $CBT
    Leadership Updates

    Live Leadership Updates

    View All

    Cabot Corporation Appoints Robert Rist as Vice President of Investor Relations and Corporate Planning

    BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced that Robert Rist has been appointed Vice President of Investor Relations and Corporate Planning. The transition will take place over the course of the first quarter of fiscal year 2026. In this expanded role, Rist succeeds Steve Delahunt, who will continue with the company as Vice President of Treasury. Rist joined Cabot in 2007 and has held a variety of leadership positions across the organization. Most recently, he served as Vice President of Corporate Strategy and Corporate Planning. His prior roles include senior-level positions within the company's Reinforcement Materials segment and finance organi

    11/3/25 4:30:00 PM ET
    $CBT
    Major Chemicals
    Industrials

    American Water Appoints New Independent Member to the Board of Directors

    American Water Works Company, Inc. (NYSE:AWK) announced today that Raffiq Nathoo has been appointed as an independent member of the company's board of directors, effective today. "American Water is pleased to have Raffiq join our board of directors," said Karl Kurz, Board Chair of American Water. "Bringing more than 30 years of experience in the international financial and capital markets, including leadership in the energy, power and utilities sectors, Raffiq will further strengthen our board, and we look forward to working with him." "We are honored to have Raffiq become part of American Water's board," said John Griffith, President and CEO of American Water. "His deep expertise in ut

    6/9/25 4:20:00 PM ET
    $AWK
    $CBT
    Water Supply
    Utilities
    Major Chemicals
    Industrials

    Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors

    Cabot Corporation (NYSE:CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a

    7/12/24 4:15:00 PM ET
    $CBT
    Major Chemicals
    Industrials

    $CBT
    Financials

    Live finance-specific insights

    View All

    Cabot Corp Reports Fourth Quarter and Fiscal Year 2025 Results

    Fourth Quarter 2025 Diluted earnings per share ("EPS") of $0.79 and Adjusted EPS of $1.70Fiscal Year 2025 Diluted EPS of $6.02 and Adjusted EPS of $7.25 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its fourth quarter and fiscal year 2025. Fiscal Year Highlights Fiscal year Diluted EPS of $6.02 and Adjusted EPS of $7.25, which represents a 3% increase in Adjusted EPS year-over-year Fiscal year segment EBIT decreased 5% in Reinforcement Materials and increased 18% in Performance Chemicals year-over-year Fiscal year 2025 Cash Flows from Operations of $665 million enabled capital investments of $274 million and the payment of $96 millio

    11/3/25 4:30:00 PM ET
    $CBT
    Major Chemicals
    Industrials

    Cabot Corporation to Announce Fourth Quarter 2025 Operating Results

    BOSTON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the fourth quarter of fiscal 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call and live webcast to review the fourth quarter results beginning at 8:00 am (ET) on Tuesday, November 4, 2025. The call will be webcast by Notified and may be accessed at Cabot's website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at https://cabotog.gcs-web.com/. ABOUT CABOT CORPORATIONCabot Corporation (NYSE

    10/3/25 8:16:07 AM ET
    $CBT
    Major Chemicals
    Industrials

    Cabot Corp Reports Third Quarter Fiscal 2025 Results

    BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its third quarter of fiscal year 2025. Q3 FY25 Key Highlights Diluted EPS of $1.86 and Adjusted EPS of $1.90, which represents a 1% decrease in Adjusted EPS compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $128 million; down 6% compared to the same quarter in the prior yearPerformance Chemicals segment EBIT of $57 million; up 4% compared to the same quarter in the prior yearReturned $64 million of cash to shareholders through dividends and share repurchasesAwarded Platinum rating from EcoVadis for exceptional leadership in sustainability performance

    8/4/25 4:32:44 PM ET
    $CBT
    Major Chemicals
    Industrials

    $CBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cabot Corporation

    SC 13G/A - CABOT CORP (0000016040) (Subject)

    11/12/24 9:50:11 AM ET
    $CBT
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

    SC 13G/A - CABOT CORP (0000016040) (Subject)

    2/12/24 9:53:45 PM ET
    $CBT
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

    SC 13G/A - CABOT CORP (0000016040) (Subject)

    2/9/24 8:50:22 AM ET
    $CBT
    Major Chemicals
    Industrials